In breast and thyroid cancers high LCN2 expression strongly correlated with advanced tumor grade and poor prognosis, but in ovarian, pancreatic and CRC it was associated well-differentiated tumors and a good prognosis (93). This evidence concerns the gene LCN2 and colorectal carcinoma.